Ensysce Biosciences, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Ensysce Biosciences, Inc. details a common stock purchase warrant issuance and a Schedule 13D filing by major shareholder Bob Gene Gower, outlining share ownership and voting agreements.